|
|
||||||||
Department of Animal Sciences, The Ohio State University, Ohio Agricultural Research and Development Center, Wooster 44691
Corresponding author: J. S. Hogan; e-mail: hogan.4{at}osu.edu.
| ABSTRACT |
|---|
|
|
|---|
Key Words: Escherichia coli FecA FepA immunoglobulin G
Abbreviation key: FecA = ferric citrate receptor, FepA = ferric enterobactin receptor, IROMP = iron-regulated outer membrane proteins
| INTRODUCTION |
|---|
|
|
|---|
Several studies have shown that antibodies to IROMP have reduced the uptake of iron by blocking the binding of ferric complexes (Murphy et al., 1990; Zhou et al., 1995; Takemura et al., 2003). Results from a study by Lin et al. (1999b) showed that polyclonal IgG from FepA-immunized cows inhibited growth of E. coli from coliform IMI. Purified IgG, isolated from FecA immunized cows, reduced iron uptake by E. coli (Takemura et al., 2003). However, the antibody did not completely inhibit the transport of iron into the cell (Takemura et al., 2003).
The ferric enterobactin and ferric citrate iron transport systems can operate simultaneoulsly in wild-type E. coli cells (Frost and Rosenberg, 1973). Therefore, antibodies targeted at one system would still allow for transport of iron through remaining systems. Vaccines targeting multiple iron-transport systems could potentially be effective at starving E. coli cells of their iron requirement, thus preventing growth in the mammary gland. The objective of the current study was to determine the in vitro synergistic effects of IgG directed against FecA and FepA on inhibiting iron uptake by E. coli isolated from bovine intramammary infections.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-
'-dipyridyl (Sigma Chemical Co., St. Louis, Mo.) and 1 mM citrate. The FecA vaccine consisted of 400 µg of antigen in 5 mL of PBS, emulsified in 5 mL of Freunds incomplete adjuvant (Difco Laboratories, Detroit, MI), so that 10-mL subcutaneous injections were administered posterior to the scapula. Vaccinated heifers received a primary immunization and boosters 14, 28, and 42 d later. A total of 100 mL of blood were collected from each heifer 63 d after the primary immunizations from both vaccinated and control groups. Serum was collected from d-63 samples and pooled within treatment groups. Using methods described previously by Lin et al. (1999b), immunoglobulin G was purified from pooled serum by ammonium sulfate precipitation followed by protein G affinity chromatography.
Source of Anti-FepA Immunoglobulin G
Anti-FepA IgG was isolated and purified by Lin et al. (1999b). Cows were vaccinated with 100 or 500 µg of FepA protein suspended in 5 mL of PBS and 5 mL of Freunds incomplete adjuvant. Cows received a primary immunization at 200 DIM and booster immunizations 14 and 28 d later. Immunoglobulin G responses did not differ between doses; therefore, serum samples from d 35 following primary immunization were pooled and used for IgG purification (Lin et al., 1999b). Anti-FepA IgG was stored at 70°C until used in the assays.
Antibody Titers
Antibody titers to FepA and FecA proteins were determined by ELISA (Lin et al., 1998a) for pooled IgG samples from FecA-immunized heifers, control heifers, and FepA-immunized cows. Purified IgG concentration used to determine antibody titers to FecA and FepA was 4 mg/mL diluted in PBS. The coating antigens were purified FecA or FepA.
Iron Transport Assays
Nonspecific induction of high-affinity iron acquisition systems.
Six E. coli isolates from cases of naturally occurring IMI were tested under culture conditions known to induce high-affinity iron acquisition systems. Each isolate had previously been shown to express both FecA and FepA following culture in vitro (Lin et al., 1998b; 1999a). Bacteria were stored in trypticase soy broth containing 20% glycerine at 70°C. Escherichia coli were grown to mid-log phase in 10 mL of chemically defined medium (Bacto-Synthetic broth, Difco Laboratories) for 18 h at 37°C and 200 rpm. The cells were washed twice and resuspended to the original volume in PBS with 200 µM
-
'-dipyridyl. A 2-mL portion of the washed cells was inoculated into 10 mL of the chemically defined medium plus 200 µM
-
'-dipyridyl and incubated for 3 h at 37°C and 200 rpm. The cells were centrifuged and washed twice in PBS with 200 µM
-
'-dipyridyl. The cells were resuspended to approximately 107 cells/mL in uptake medium (Hussein et al., 1981). The bacterial suspension was serially diluted in PBS, spotted on MacConkey agar plates, and incubated for 12 h at 37°C for determining cfu/mL.
The bacterial suspension (1.25 mL) was incubated for 30 min on ice with 1.1 mL of antibody dilution in 10 x 75-mm polystyrene culture tubes. Five antibody treatments were used in dilutions for final assay concentrations: 1) control IgG (3 mg/mL), 2) anti-FecA IgG (3 mg/mL), 3) anti-FepA IgG (3 mg/mL), 4) both anti-FepA (3mg/mL) and anti-FecA IgG (3mg/mL) (6mg/mL total), and 5) PBS (0 mg/mL) as a negative control. Nitrilotriacetate (0.1 mM) was added to the assay to suppress non-specific iron uptake and incubated at 37°C for 5 m (Takemura et al., 2003). The 55Fe cocktail was added to the assay at final concentrations of 10 µM FeCl3, 100 µM soduim citrate, and 0.2 µCi 55Fe/mL (~0.05µM 55Fe) and incubated on a dry block heater at 37°C. Testing procedures were those described by Takemura et al. (2003). The iron transport assay was repeated twice for each E. coli isolate. The measurements were expressed as the number of 55Fe atoms taken up per colony-forming unit, and then transformed to log10 for statistical analysis.
Induction of FecA.
Iron uptake by E. coli isolates was tested in Fe-depleted conditions to selectively induce the expression of FecA (Hussein et al., 1981). Culture medium was the chemically defined medium containing 200 µM
-
'-dipyridyl and 1 mM citrate. Bacteria were washed in PBS with 200 µM
-
'-dipyridyl and 1 mM citrate. Other experimental factors including bacterial isolates, IgG treatments, and incubation conditions were those described previously for testing isolates in culture conditions to induce high-affinity iron acquisition systems.
Synergistic effects of IgG.
The possible synergistic effects of different combinations of IgG from the three treatment groups on iron uptake were measured in conditions that selectively induced the expression of FecA. Cells were washed in a 1-mM solution of citrate and inoculated into 10 mL of chemically defined medium containing 200
M
-
'-dipyridyl and 1 mM citrate. Six antibody treatments were used with final assay concentrations of 6 mg/mL: 1) anti-FepA IgG, 2) anti-FecA IgG, 3) both anti-FepA (3 mg/mL) and anti-FecA IgG (3 mg/mL), 4) both anti-FepA (3 mg/mL) and control IgG (3 mg/mL), 5) both anti-FecA (3 mg/mL) and control IgG (3 mg/mL), and 6) PBS (0 mg/mL) as a negative control. Other experimental factors including bacterial isolates and incubation conditions were described previously for testing isolates in culture conditions to induce the expression of FecA.
Statisical Analysis
Differences among treatments for log10 55Fe atoms/cfu were tested by least squares ANOVA (SAS Inst., Inc., Cary, NC). The variables were tested for treatment effects within sample time. The variables were also tested for treatment effects partitioned into multiple contrasts. Preplanned contrasts among treatments for synergistic effects of IgG included 1) IgG vs. negative control; 2) immunized IgG vs. control IgG; 3) anti-FecA vs. anti-FepA IgG; 4) anti-FecA/anti-FepA IgG combination vs. other treatments with FecA IgG; and 5) anti-FecA/anti-FepA IgG combination vs. other treatments with anti-FepA IgG.
| RESULTS |
|---|
|
|
|---|
Iron Transport Assays
Nonspecific induction of high-affinity iron acquisition systems.
The presence of IgG decreased iron uptake compared with PBS only (Figure 1
). Uptake of 55Fe was comparable between anti-FepA and anti-FecA treatments (P > 0.05). The combination of anti-FecA/anti-FepA IgG reduced iron transport at 5 min compared with anti-FepA IgG alone (P < 0.001), control IgG (P < 0.01), and anti-FecA IgG (P = 0.09). After a 10-min incubation, the combination of anti-FecA/anti-FepA IgG significantly reduced iron transport into the E. coli cells compared with anti-FepA IgG (P < 0.05). The combined effects of both anti-FecA and anti-FepA IgG had greater reduction in iron transport than either treatment alone after 5 min.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The FecA (Lin et al., 1999a) and FepA (Rutz et al., 1991) are highly conserved antigenic outer membrane proteins expressed by E. coli isolates tested in the present study (Lin et al., 1999a, b). These characteristics make them attractive candidates for vaccination against bovine mastitis-causing coliform bacteria. Immunization, yielding antibodies that block one outer membrane protein, may force the uptake through the other coinciding system. Therefore, antibodies specific for FecA and FepA further blocked iron uptake into the bacterial cells, but did not completely starve the cell of its iron requirement in vitro. The consequences of the partial denial of iron to bacteria were exemplified in earlier trials whereby IgG from cows vaccinated with FecA effectively reduced iron uptake in the in vitro assay (Takemura et al., 2003), but did not reduce total bacterial growth over constitutive antibody from unvaccinated cows (Takemura et al., 2004).
Escherichia coli can induce other iron acquisition systems including ferrichrome, ferric aerobactin, and ferric rhodotrulate (Briat, 1992; Neilands, 1994). In the iron-starved environment of this assay, with the major uptake systems blocked, these less common transport systems could have been induced to obtain iron. Ferric dicitrate has a molecular mass of 434 kDa, which is small enough to diffuse through channel porins (Braun, 1997; Ferguson et al., 2002). In the presence of citrate, ferric citrate complexes form, but transport through the outer membrane protein FecA is blocked by antibody. Nitrilotriacetate was added to the assay to suppress nonspecific iron transport (Takemura et al., 2003), but did not stop ferric citrate, which is small enough to pass through porin channels. This may have been another method by which E. coli was still able to acquire iron in this assay.
The hypothesis that the synergism of antibodies specific for FecA and FepA would reduce iron transport compared with either antibody source alone was supported in the current experiments. The current trial and a series of previous experiments (Lin et al., 1998b; 1999b; Takemura et al., 2003) have shown that the FepA and FecA proteins are antigenic to dairy cows, and that IgG from vaccinated cows reduce iron uptake and replication in vitro. Despite the presence of antibody specific to FecA and FepA outer membrane receptors on E. coli, these antibody sources did not completely inhibit the uptake of iron into the bacterial cell or bacterial replication. This may be attributed to nonspecific transport of iron complexes through the porin channels, the induction of other high-affinity transport systems, or the antibodies binding to areas of the IROMP that will still allow recognition of their specific iron complexes.
The cumulative results of trials on blocking iron uptake and growth of E. coli by bovine antibody specific for high-affinity ferric receptors indicates that this approach may not be feasible in lessening the incidence or severity of coliform mastitis. The concentrations of purified antibody used for in vitro iron uptake and growth inhibition trials conducted in minimal, defined media have exceeded the concentrations of antibody in complex mammary secretions. Likewise, experimental IMI data implied that vaccination with IROMP lacks efficacy. Although FecA-immunized cows had increased antibody titers to FecA, vaccination showed minimal effect on clinical severity of mastitis compared with nonimmunized control cows (Takemura et al., 2002). The myriad of high- and low-affinity iron acquisition systems of E. coli appear to allow the pathogen to acquire iron and replicate despite the presence of IgG specific for one or more IROMP.
| FOOTNOTES |
|---|
Received for publication October 6, 2003. Accepted for publication February 20, 2004.
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |